Doctors urged to prescribe Vytorin

Published: 2008-09-10 06:45:00

Updated: 2008-09-10 06:45:00

More caution should be necessary in prescribing Vytorin (ezetimibe/ simvastin) as concern about Vytorin and cancer surfaced in July, when the SEAS study was published, according to a local professor.

“A link to cancer deaths should not be assumed to be a chance finding until further data are i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK